Adjuvant checkpoint blockade following complete local therapy for melanoma metastases

Lancet. 2022 Oct 1;400(10358):1082-1083. doi: 10.1016/S0140-6736(22)01748-2. Epub 2022 Sep 10.

Authors

James W Smithy¹, Michael A Postow²

Affiliations

¹ Melanoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
² Melanoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: postowm@mskcc.org.

PMID: 36099925
DOI: 10.1016/S0140-6736(22)01748-2

No abstract available

Publication types

Comment

MeSH terms

Humans
Ipilimumab / therapeutic use
Melanoma* / drug therapy
Melanoma* / pathology

Substances

Ipilimumab